Novavax initiated efficacy trial of COVID-19 vaccine in South Africa
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…
On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…
On Aug. 15, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to…
On Aug. 14, 2020, McKesson announced that it had expanded its existing partnership with the Centers for Disease…
On Aug. 14, 2020, research supported by the National Institutes of Health (NIH) delineated how two relatively common…
On Aug. 14, 2020, AstraZeneca concluded an agreement with the European Commission (EC) to supply up to 400…
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
On Aug. 14, 2020, a global leader in the healthcare industry, McKesson announced it will expand its existing…
On Aug. 13, 2020, the National Institutes of Health (NIH) announced a new interactive mapping tool that showcases…
On Aug. 13, 2020, data from the World Health Organization/United Nations International Children’s Emergency Fund Joint Monitoring Programme…
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
On Aug. 12, 2020, Thermo Fisher Scientific announced it had committed to supporting the efforts of historically black…
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
On Aug. 12, 2020, Celdara Medical announced that the National Institute of Allergy and Infectious Diseases (NIAID) of…
On Aug. 12, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to NS Pharma’s Viltepso…
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
On Aug. 11, 2020, Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as…
On Aug. 11, 2020, Bio-Techne announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds…
On Aug. 11, 2020, LabCorp announced details of a no charge antibody testing program in response to federal…
On Aug. 11, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…
On Aug. 11, 2020, Hologic announced that it has validated use of its Aptima® and Panther Fusion® molecular…
On Aug. 10, 2020, CBR by Generate Life Sciences, the world’s largest private newborn stem cell bank, and…
On Aug. 10, 2020, Gilead Sciences announced that it had submitted a New Drug Application (NDA) to the…
On Aug. 10, 2020, scientists from Epitracker and the Translational Genomics Research Institute (TGen) announced the results from…